Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

AMPLIFICATION OR OVEREXPRESSION OF MLL SEPTIN-LIKE FUSION (MSF) AND SEPTIN9 AND METHODS RELATED THERETO12

  • Read more about AMPLIFICATION OR OVEREXPRESSION OF MLL SEPTIN-LIKE FUSION (MSF) AND SEPTIN9 AND METHODS RELATED THERETO12
US Application 60/448,700
Filed on 2003-02-19

Use Of Layered Expression Scanning (LES) For Multiwell Plates

  • Read more about Use Of Layered Expression Scanning (LES) For Multiwell Plates
US Application 60/400,874
Filed on 2002-08-02

ABCA13 Nucleic Acids and Proteins, and Uses Thereof

  • Read more about ABCA13 Nucleic Acids and Proteins, and Uses Thereof
US Application 60/454,502
Filed on 2003-03-12

Leu574 of HIF-1alpha as a Molecular Basis for Therapeutic Development

  • Read more about Leu574 of HIF-1alpha as a Molecular Basis for Therapeutic Development
US Application 60/465,565
Filed on 2003-04-23

"Methods and Composition for the Diagnosis of Neuroendocrine Lung Cancer"

  • Read more about "Methods and Composition for the Diagnosis of Neuroendocrine Lung Cancer"
US Application 60/423,380
Filed on 2002-11-04

METHOD AND MATERIALS FOR PROMOTING MIGRATION OF T CELLS TO THE VASCULATURE OF A TUMOR

  • Read more about METHOD AND MATERIALS FOR PROMOTING MIGRATION OF T CELLS TO THE VASCULATURE OF A TUMOR
US Application 60/447,497
Filed on 2003-02-14

The Use Of A Smad3 Inhibitor In The Treatment Of Fibrosis Dependent On Epithelial To Mesenchymal Transition As In The Eye And Kidney

  • Read more about The Use Of A Smad3 Inhibitor In The Treatment Of Fibrosis Dependent On Epithelial To Mesenchymal Transition As In The Eye And Kidney
US Application 60/441,297
Filed on 2003-01-17

Inhibition of Ubiquitin-Mediated Processes by UBA Domain Peptides

  • Read more about Inhibition of Ubiquitin-Mediated Processes by UBA Domain Peptides
US Application 60/464,658
Filed on 2003-04-23

Synthesis of Proteins by Cell-Free Protein Expression

  • Read more about Synthesis of Proteins by Cell-Free Protein Expression
US Application 60/454,013
Filed on 2003-03-11

METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL ANION DONORS

  • Read more about METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL ANION DONORS
US Application 60/389,757
Filed on 2002-06-17

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • Page 180
  • Page 181
  • Page 182
  • Page 183
  • Page 184
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health